ANI Pharmaceuticals Inc (ANIP)
Total asset turnover
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue (ttm) | US$ in thousands | 454,334 | 417,871 | 370,670 | 328,961 | 287,962 | 256,461 | 229,582 | 208,526 | 202,730 | 205,047 | 205,953 | 205,960 | 203,642 | 194,356 | 195,209 | 203,434 | 206,547 | 215,703 | 215,069 | 207,980 |
Total assets | US$ in thousands | 904,422 | 889,914 | 859,341 | 765,224 | 760,087 | 739,110 | 751,334 | 744,846 | 771,598 | 470,454 | 480,159 | 463,843 | 461,190 | 462,581 | 465,391 | 482,232 | 456,789 | 456,775 | 446,906 | 434,390 |
Total asset turnover | 0.50 | 0.47 | 0.43 | 0.43 | 0.38 | 0.35 | 0.31 | 0.28 | 0.26 | 0.44 | 0.43 | 0.44 | 0.44 | 0.42 | 0.42 | 0.42 | 0.45 | 0.47 | 0.48 | 0.48 |
December 31, 2023 calculation
Total asset turnover = Revenue (ttm) ÷ Total assets
= $454,334K ÷ $904,422K
= 0.50
Total asset turnover is a financial ratio that measures a company's ability to generate revenue from its assets. The ratio is calculated by dividing the company's net sales by its average total assets.
Based on the data provided, we can see that ANI Pharmaceuticals Inc's total asset turnover has been showing a positive trend over the past eight quarters. The total asset turnover ratio has increased steadily from 0.30 in Q1 2022 to 0.54 in Q4 2023, indicating that the company has become more efficient in generating sales from its total assets.
A higher total asset turnover ratio suggests that the company is using its assets more effectively to generate sales, which could be a sign of operational efficiency and improved financial performance. In the case of ANI Pharmaceuticals Inc, the increasing trend in total asset turnover indicates that the company may be experiencing growth in sales relative to its total assets.
Overall, the improving total asset turnover trend for ANI Pharmaceuticals Inc is a positive sign and suggests that the company is effectively utilizing its assets to drive revenue generation.
Peer comparison
Dec 31, 2023